TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
about
HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microgliaOATL1, a novel autophagosome-resident Rab33B-GAP, regulates autophagosomal maturationTWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptorTWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modulesAtg9a controls dsDNA-driven dynamic translocation of STING and the innate immune responsePrinciples of antibody-mediated TNF receptor activationTWEAK and the progression of renal disease: clinical translationCrystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor BindingThe tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expressionTWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21Apoptosis-related genes change their expression with age and hearing loss in the mouse cochlea.An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure.A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.Differential utilization of NF-kappaB RELA and RELB in response to extracellular versus intracellular polyIC stimulation in HT1080 cells.The LC3 recruitment mechanism is separate from Atg9L1-dependent membrane formation in the autophagic response against SalmonellaCell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κB signalingBAC clones generated from sheared DNA.Dennd3 functions as a guanine nucleotide exchange factor for small GTPase Rab12 in mouse embryonic fibroblasts.Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.The noncanonical NF-κB pathway.Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected]TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokineTWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus.TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domainMonocarboxylate transporter-1 is required for cell death in mouse chondrocytic ATDC5 cells exposed to interleukin-1beta via late phase activation of nuclear factor kappaB and expression of phagocyte-type NADPH oxidase.Transgenic mouse model harboring the transcriptional fusion ccl20-luciferase as a novel reporter of pro-inflammatory response.A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.Development of an Fn14 agonistic antibody as an anti-tumor agent.TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cellsTargeting signaling factors for degradation, an emerging mechanism for TRAF functionsFunctions of NF-kappaB1 and NF-kappaB2 in immune cell biologyIntegration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway.SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.TRAF2: a double-edged sword?Transcriptomic Signatures of Auger Electron Radioimmunotherapy Using Nuclear Targeting (111)In-Trastuzumab for Potential Combination Therapies.Atg16L1, an essential factor for canonical autophagy, participates in hormone secretion from PC12 cells independently of autophagic activity.Polyubiquitin-sensor proteins reveal localization and linkage-type dependence of cellular ubiquitin signaling.The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity
P2860
Q21245231-2513EB36-7646-4DF6-81EF-0C8E3F8B3547Q24295224-9DF3C6DE-7F85-45E5-A8F7-96D8EF67CDD6Q24300508-9B1D822E-AAB4-467F-BEDD-CDB3C0242FA0Q24300996-F28F8ED5-E9AC-42C1-BC5C-88F4238E1ED1Q24553352-7180852A-97D5-4A49-B712-5435F2F0DA21Q24643548-744C6239-2884-49AE-AE77-9B312D214284Q26796270-652F220E-F186-47A2-B141-75208EB64B5BQ26996775-9DF25D68-6D24-458C-AE5A-904CDD508B87Q27678102-6F44EE6E-1195-44BF-8283-2A571A03443AQ28299334-B33853C6-E9D8-4EB7-B74E-7CD50FE0DE1FQ28749137-96B9D66D-392B-47A1-B184-543E2DA90CDAQ30482886-5B17334A-C882-4F33-B384-7D7D6AA873DEQ30484302-5E765D6D-80EE-40E0-A8D8-5982E8EA69F2Q30496163-08D309F4-838E-48DD-8B05-9C5EA4498B19Q30498322-C6908F1C-607A-4201-8005-6B039D3465F0Q30502008-C5042472-860C-41BD-B3B3-BC25904A7B05Q30583559-737EEE48-8F5B-43D9-AC1B-2F3257391552Q33263351-FAA65168-FFE9-4582-A1E8-FC0A3C00C523Q33619407-8B504902-F604-4A6C-B3E7-8A7E92FB04D3Q33885155-10892DA8-C86F-4353-A645-028EBD8E63D7Q34031207-CDE3EC79-88C6-4128-B7F2-56BFEDD029E8Q34043446-71D90BF5-4D9E-4699-AC3D-C92D582B4C9EQ34132318-B68E27C0-BB27-4546-996E-4A9B8C5BC2FCQ34206359-41E1CABF-CB86-44B1-8733-584BB90CA2F9Q34764239-CE9135EF-19FC-4899-9B2E-3CCC9D2C4705Q34869339-34C5323B-0296-48BD-9BD0-6F5DEC0989CEQ35050296-AF0B48AD-C633-4353-AA27-27691B5A0F1BQ35083662-28025C1B-3316-4928-859A-EEA5F7078195Q35095325-B68DCE1E-6D1F-46E1-B3B7-82001311F610Q35556794-1A65DDFD-C997-47AB-89D3-805D8885BBBCQ35605699-D52DCDDE-3FE6-4D87-A0CF-C111F58B0A4EQ35759267-CFADAEB3-5F69-4E94-9ED0-709BC5F6AC31Q35815962-0FFC3409-7BEE-411C-BC50-763FAEC11A00Q35954703-3CD5BDA4-6471-40FB-B25D-621D936313C6Q36033829-ADB1F1EB-2A3D-4164-9D16-FFCF63D3F2EBQ36053266-810B1E0C-941B-4D2F-B809-1772E627D926Q36148279-72ED43D6-282B-45B6-BCCB-E61FCA979AACQ36161685-2E6E45BB-B873-464C-A5D9-40A004A78EF7Q36225539-EBD0F1A0-8B25-4313-BC69-C049265FF05EQ36458661-A361A431-C235-49E0-A1F6-BAE047F927C8
P2860
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
@ast
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
@en
type
label
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
@ast
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
@en
prefLabel
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
@ast
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
@en
P2093
P2860
P356
P1476
TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation
@en
P2093
Hideo Yagita
Masafumi Nakayama
Shoji Yamaoka
Tatsuya Saitoh
P2860
P304
36005-36012
P356
10.1074/JBC.M304266200
P407
P577
2003-07-01T00:00:00Z